← Leaderboards
Samuel Goldfarb
Cincinnati Childrens Hosp Med Ctr
$2,417,127
Attributed
$7,251,380
Total exposure
1
Grants
0
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $1.5M · FY2021–25$2M$1.5M$1M$500K$0
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$7,251,380 · 1
By mechanism
R01$7,251,380 · 1
Top collaborators
- Stella Margaret Davies5 shared
- Jason C Woods5 shared
Most similar at Cincinnati Childrens Hosp Med Ctr
Same institution · by research overlap
- Nancy Ratner$25,011,276
- Donald M Bers$56,507,614
- Susanne Irmtraud Wells$12,656,530
- Jeffery D Molkentin$48,923,505
- Christina Gross$5,984,277
Others in their field
Other Emerging Leaders on “Diagnosis”
- Bambra Strokes · Ppd Development Lp$526,656,217
- Leonard Freedman · Leidos Biomedical Research, Inc.$337,858,596
- Ethan Dmitrovsky · Leidos Biomedical Research, Inc.$141,100,782
- Lynn Briscoe · Leidos Biomedical Research, Inc.$93,294,869
- Marlene Ann Cooper · Harvard University D/B/A Harvard School Of Public Health$71,912,072
- Leonard Freedmand · Leidos Biomedical Research, Inc.$66,248,714
Research focus
Diagnosis10 Year OldAdultData CollectionAffectBiologicalAllogenicBiological TestingAnatomyComplicationBronchiolitis ObliteransBronchoalveolar Lavage FluidBronchoscopyCalendarChildChildhoodClinical DataClinical PhenotypeClinical RiskCohortCohort StudiesBiopsyCollectionDiagnostic
Grant awards (5)
TRANSPIRE: A Prospective Cohort Study of Lung Injury After Hematopoietic Stem Cell Transplant in Children.$1,447,360
R01 · FY2025 · HL
TRANSPIRE: A Prospective Cohort Study of Lung Injury After Hematopoietic Stem Cell Transplant in Children.$1,418,412
R01 · FY2024 · HL
TRANSPIRE: A Prospective Cohort Study of Lung Injury After Hematopoietic Stem Cell Transplant in Children.$1,447,360
R01 · FY2023 · HL
TRANSPIRE: A Prospective Cohort Study of Lung Injury After Hematopoietic Stem Cell Transplant in Children.$1,453,734
R01 · FY2022 · HL
TRANSPIRE: A Prospective Cohort Study of Lung Injury After Hematopoietic Stem Cell Transplant in Children.$1,484,514
R01 · FY2021 · HL